CSIMarket
 


Cumberland Pharmaceuticals Inc   (CPIX)
Other Ticker:  
 
 

CPIX's Net Cash Flow Growth by Quarter and Year

Cumberland Pharmaceuticals Inc 's Net Cash Flow results by quarter and year




CPIX Net Cash Flow (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 1.23 -10.32 3.39
III Quarter September - 6.03 2.35 7.04
II Quarter June - -3.66 0.64 -0.36
I Quarter March -1.19 -3.33 -10.15 0.46
FY   -1.19 0.27 -17.48 10.53



CPIX Net Cash Flow first quarter 2019 Y/Y Growth Comment
Cumberland Pharmaceuticals Inc in the first quarter recorded net cash outflow of $ -1.19 millions.

According to the results reported in the first quarter, Cumberland Pharmaceuticals Inc achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Cumberland Pharmaceuticals Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the first quarter.




CPIX Net Cash Flow ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - 156.6 % -66.62 % -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cumberland Pharmaceuticals Inc 's first quarter 2019 Net Cash Flow $ -1.19 millions CPIX's Income Statement
Cumberland Pharmaceuticals Inc 's first quarter 2018 Net Cash Flow $ -3.33 millions Quarterly CPIX's Income Statement
New: More CPIX's historic Net Cash Flow Growth >>


CPIX Net Cash Flow (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - -79.6 % - -51.85 %
III Quarter September - - 267.19 % -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Cumberland Pharmaceuticals Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CPIX's I. Quarter Q/Q Net Cash Flow Comment
I. Quarter 2019 net cash outflow of -1.19 millions by Cumberland Pharmaceuticals Inc appear even more unfavourable considering the net cash outflow 1.23 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Cumberland Pharmaceuticals Inc achieved highest sequential Net Cash Flow growth. While Cumberland Pharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CPIX's I. Quarter Q/Q Net Cash Flow Comment
Recent accomplishment of -1.19 millions by Cumberland Pharmaceuticals Inc appear even more unfavourable considering the 1.23 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry Cumberland Pharmaceuticals Inc achieved highest sequential Net Cash Flow growth. While Cumberland Pharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Cumberland Pharmaceuticals Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Net Cash Flow 12 Months Ending $ 2.42 $ 0.27 $ -11.28 $ -14.96 $ -10.65
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) 783.28 % - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 93 # 0 # 0 # 0 # 0




Cumulative Net Cash Flow growth Comment
In the Mar 31 2020 period, Cumberland Pharmaceuticals Inc had cumulative twelve months Net Cash Flow of $ 2 millions compare to net cash outflow of $ -11 millions a year ago.
Even more so, not just that Major Pharmaceutical Preparations company has regained the prosperity, it is already heading full steam and showing above usual Net Cash Flow gain, from the twelve months ending in the quarter before of 783.28 % from $0.27 millions.
Singns of recovery, but very slow one, showing less then standard 783.28 % Net Cash Flow increase, from $0.27 millions from the twelve months ending in the quarter Dec 31 2019 Gracie Young mentioned.

Cumberland Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
783.28 %
273.13 %
-97.35 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 12
S&P 500 # 93
Cumulative Net Cash Flow growth Comment
In the Mar 31 2020 period, Cumberland Pharmaceuticals Inc had cumulative twelve months Net Cash Flow of $ 2 millions compare to net cash outflow of $ -11 millions a year ago.
Even more so, not just that CPIX has returned to prosperity, Cumberland Pharmaceuticals Inc by this time is heading full steam and recording higher than usual Net Cash Flow rise, from the twelve months ending in the quarter Dec 31 2019 of 783.28 % from $0.27 millions.
It is progress, but modest, reporting below average 783.28 % Net Cash Flow increase, from $0.27 millions from the period from Dec 31 2019 to Mar 31 2019 Gracie Young continued.

Cumberland Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
783.28 %
273.13 %
-97.35 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 12
S&P 500 # 93




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
CPIX's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for CPIX's Competitors
Net Cash Flow Growth for Cumberland Pharmaceuticals Inc 's Suppliers
Net Cash Flow Growth for CPIX's Customers

You may also want to know
CPIX's Annual Growth Rates CPIX's Profitability Ratios CPIX's Asset Turnover Ratio CPIX's Dividend Growth
CPIX's Roe CPIX's Valuation Ratios CPIX's Financial Strength Ratios CPIX's Dividend Payout Ratio
CPIX's Roa CPIX's Inventory Turnover Ratio CPIX's Growth Rates CPIX's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2020
Ridgefield Acquisition Corp -18.20 %$ -18.201 millions
Haemonetics Corporation -24.77 %$ -24.765 millions
Chf Solutions Inc -26.94 %$ -26.943 millions
Epizyme Inc -30.98 %$ -30.978 millions
Sunesis Pharmaceuticals Inc -35.11 %$ -35.106 millions
Paratek Pharmaceuticals Inc -36.08 %$ -36.079 millions
Ensign Group Inc -40.04 %$ -40.039 millions
Tearlab Corp -41.34 %$ -41.344 millions
Moleculin Biotech Inc -44.54 %$ -44.539 millions
Biosig Technologies Inc -47.70 %$ -47.695 millions
Hoth Therapeutics Inc -47.70 %$ -47.703 millions
Repligen Corp -49.89 %$ -49.892 millions
Cymabay Therapeutics Inc -58.31 %$ -58.311 millions
Chemocentryx Inc -60.47 %$ -60.470 millions
Community Health Systems Inc -62.96 %$ -62.963 millions
Imac Holdings Inc -68.37 %$ -68.367 millions
Myos Rens Technology Inc -71.86 %$ -71.861 millions
Recro Pharma Inc -74.59 %$ -74.595 millions
Healthlynked Corp -75.21 %$ -75.213 millions
Agios Pharmaceuticals Inc -75.22 %$ -75.222 millions
Seelos Therapeutics Inc -78.43 %$ -78.427 millions
Immucell Corp -80.01 %$ -80.007 millions
Rezolute Inc -83.69 %$ -83.693 millions
Zoetis Inc -86.51 %$ -86.508 millions
Surge Holdings Inc -90.48 %$ -90.483 millions
Spectrum Pharmaceuticals Inc -95.02 %$ -95.021 millions
Nascent Biotech Inc -95.03 %$ -95.033 millions
Vistagen Therapeutics Inc -95.72 %$ -95.718 millions
Petvivo Holdings Inc -97.87 %$ -97.872 millions
Casi Pharmaceuticals Inc -98.30 %$ -98.300 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SKYS's Profile

Stock Price

SKYS's Financials

Business Description

Fundamentals

Charts & Quotes

SKYS's News

Suppliers

SKYS's Competitors

Customers & Markets

Economic Indicators

SKYS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071